Drug Topics

JULY 11, 2023

Underlying HIV infection was independently associated with neurocognitive long COVID symptoms.

360

360

PhRMA

JULY 11, 2023

Recent studies add to the growing body of evidence questioning the value of the current 340B program and whether it’s benefiting patients as Congress intended.

261

261

Drug Topics

JULY 11, 2023

Researchers encourage physicians to personalize care plans to ensure that more patients adhere to their inhalers.

360

360

PharmaVoice

JULY 11, 2023

With a purchase of the pharma giant’s Kenilworth campus, Onyx Equities is looking to make the spot a go-to biotech hub.

189

189

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Drug Topics

JULY 11, 2023

Vaccination can minimize health care costs associated with influenza.

Vaccines 358

Vaccines 358

Pharmacy Times

JULY 11, 2023

Pharmaceuticals are a critical and often lifesaving tool for managing disease, but we will never solve our chronic disease crisis through a mindset of mere management.

130

130

Pharmacy Times

JULY 11, 2023

The risk of heart failure was higher in low- and middle-income countries when compared to high-income countries.

101

101

Drug Topics

JULY 11, 2023

A new study has been published in which researchers attest to the importance of screening vigilance in regards to HIV and HBV.

190

190

Pharmacy Times

JULY 11, 2023

Wide-ranging options for HIV pre-exposure prophylaxis initiation in different settings and though different providers should be maintained to ensure underserved populations get adequate treatment options.

101

101

Drug Topics

JULY 11, 2023

A study examined STI rates following doxycycline post-exposure prophylaxis to see if it could reduce infection rates.

190

190

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

PharmaVoice

JULY 11, 2023

After taking the reins from the company’s founding CEO, Douglas Treco is guiding Inozyme through the clinic.

100

100

STAT

JULY 11, 2023

Takeda announced Tuesday that it has voluntarily withdrawn its application to the Food and Drug Administration for its dengue vaccine, making it unclear when or if the vaccine will be licensed in this country. The company said in a press release that it will review whether to proceed with trying to bring the vaccine to the U.S. market. The vaccine has already been approved in the European Union, the United Kingdom, Brazil, Argentina, Indonesia, and Thailand.

Vaccines 98

Vaccines FDA 98

Fierce Healthcare

JULY 11, 2023

Hospitals told a major Senate panel that a $385 million bucket of annual emergency preparedness funding up for reauthorization should “be at least doubled” if the country’s healthcare system is to | A flat reauthorization of the money spent preparing hospitals for public health emergencies is insufficient "to help rebuild the program after years of underfunding," the hospital lobby told lawmakers Monday.

Hospitals 98

Hospitals 98

Pharmaceutical Commerce

JULY 11, 2023

The National Alliance of Healthcare Purchaser Coalitions releases resources for employers/health plan purchasers to offer insights on PBMs role in high prescription drug costs.

98

98

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

STAT

JULY 11, 2023

Melanie Lawrence doesn’t think she’ll live long enough to see her son graduate college. Lawrence, a patient with cystic fibrosis from Massachusetts, has been on antibiotics almost her whole life. Throughout her childhood and early teenage years, the antibiotics were “highly effective,” but with Lawrence now in her 40s, “the bacteria in my lungs are resistant to nearly all antibiotics,” she told the Senate HELP subcommittee on primary health & retirem

98

98

pharmaphorum

JULY 11, 2023

TIGIT underwhelms again as Novartis ducks out Phil.

98

98

Fierce Healthcare

JULY 11, 2023

Price transparency has been a key focus for policymakers looking to address rising health costs, but experts say breaking through that black box won't solve the problem wholesale. | Price transparency has been a key focus for policymakers looking to address rising health costs, but experts say breaking through that black box won't solve the problem wholesale.

98

98

The FDA Law Blog

JULY 11, 2023

By Sara W. Koblitz — One of the most important questions FDA has to answer is whether a given product is appropriately characterized as a drug, biologic, device, food, cosmetic, or something entirely different. As we have explained before , that distinction is critical to assigning a particular product to the appropriate regulatory scheme. While it is exceedingly obvious that some products, like eyeshadow for example, are cosmetics, or a pacemaker is a device, it can get thorny where the disti

FDA 95

FDA 95

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Fierce Healthcare

JULY 11, 2023

Drug shortages can drive up costs for patients, and a new analysis suggests ways these issues could be avoided. | Prior research about drug shortages looked at frequency and intensity. New Rand research looks at how they affect consumers.

98

98

Pharmacy Times

JULY 11, 2023

HCV infection is mostly curable and treated with antiviral medications, which can clear the virus from the body.

94

94

Fierce Healthcare

JULY 11, 2023

SimpliFed, a national provider of lactation and baby feeding support, is now in network with Optum’s VA Community Care Network. | The new deal grants female veterans in the eastern half of the U.S. access to virtual baby feeding support, available seven days a week, at no cost to the patient and no limits on number of appointments.

98

98

Pharmacy Times

JULY 11, 2023

The use of psilocybin and psychedelic therapy can be a helpful tool for individuals with AUD and could have a positive outcome that can result in self compassion.

94

94

Fierce Healthcare

JULY 11, 2023

After a wild ride in 2020 and 2021, the digital health funding market is entering a new reality with fewer deals and smaller average check sizes. | After a wild ride in 2020 and 2021, the digital health funding market is entering a new reality with fewer deals and smaller average check sizes.

96

96

pharmaphorum

JULY 11, 2023

Embattled Better gets FDA okay for lead DTx product Phil.

FDA 88

FDA 88

Fierce Healthcare

JULY 11, 2023

Virgina providers Riverside Health System and UVA Health have cut a strategic partnership deal that expands complex care access and coordination for patients in the eastern part of the state. | The new strategic agreement gives the academic health system a 5% ownership stake in nonprofit Riverside Health System. With that, UVA Health has committed to expanding care in Riverside's markets as well as to a bidirectional sharing of expertise on clinical program development, medical research and

96

96

pharmaphorum

JULY 11, 2023

Sensorion files to start trials of deafness gene therapy Phil.

81

81

STAT

JULY 11, 2023

Frustration was boiling into open conflict within NaviHealth, a company that uses computer predictions to help control the cost of caring for millions of older and disabled Americans on privatized Medicare plans. The source of the outrage was not a customer or a salesperson, but an algorithm — specifically one that was being used to predict the amount of care needed by seriously ill patients.

Communication 76

Communication Insurance 76

European Pharmaceutical Review

JULY 11, 2023

The first CD20xCD3 T-cell-engaging bispecific antibody (BsAb) treatment to be approved in Europe for diffuse large B-cell lymphoma (DLBCL) has been granted conditional marketing authorisation. European approval is based on results from the Phase I/II NP30179 study of Columvi ® (glofitamab). Given as a fixed course, the BsAb treatment induced a complete response (CR) in 35.2 percent of the heavily pre-treated or refractory DLBCL participants.

FDA 75

FDA Hospitals 75

STAT

JULY 11, 2023

Japanese drugmaker Eisai said Tuesday that Ivan Cheung, chairman of its U.S. operations and global head of its Alzheimer’s disease unit, will retire at the end of the month. The surprise announcement comes just days after Eisai won final approval in the U.S. for its Alzheimer’s drug Leqembi. Cheung will be replaced in his capacity as head of the Alzheimer’s unit by his brother-in-law Keisuke Naito, 34, who is currently chief ecosystem officer and chief strategy officer.

76

76

Pharmaceutical Technology

JULY 11, 2023

Iovance Biotherapeutics completes a preliminary analysis after the US' FDA found the trial design acceptable for accelerated approval.

FDA 75

FDA 75

STAT

JULY 11, 2023

“W hen I use a word,” one of 19th century British author and mathematician Lewis Carroll’s characters once said, “ it means just what I choose it to mean — neither more nor less.” Though he was a formidable philosopher and logician, Carroll likely would be stymied by the circular logic that justifies the definition of “recovery” currently used to support critical federal substance use disorder programs and activities.

75

75

pharmaphorum

JULY 11, 2023

EMA probes suicide risk with Novo Nordisk obesity drugs Phil.

75

75

STAT

JULY 11, 2023

Several thousand research fellows at the National Institutes of Health want to unionize, in large part because they want to raise their pay stipends to something resembling a living wage near the agency headquarters in Bethesda, Md. But with a Congress that is looking on in suspicion at the NIH’s research and a debt ceiling deal that limits budget increases, where is the money going to come from?

75

75